Example: Heart Attack

Search clinical trials for: Threonine

Total 36 results

NCT02423460

Completed

Threonine Requirement in IBD Adults and Healthy Adult Controls

Conditions: Ulcerative Colitis; Crohn's Disease; Healthy
NCT02364843

Enrolling by invitation

A Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months

Conditions: Surgical Infants on NG/NJ/J/G-tube Feeds; Tracheoesophageal Fistula; Pierre-Robin Syndrome; Diaphragmatic Hernia
NCT04585087

Recruiting

Length of Adaptation and Threonine Requirement

Conditions: Healthy
NCT02660892

Completed

Determination of Threonine Requirements in Healthy School-aged Children

Conditions: Threonine Requirements in Children
NCT01032616

Completed

Uptake and Utilization of Amino Acids by Splanchnic Bed

Conditions: Healthy Males
NCT02991274

Completed

ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory

Conditions: Locally Advanced or Metastatic EGFR(+) NSCLC Patients
NCT00896389

Completed

Salt Loading and Thiazide Intervention Study

Conditions: Hypertension
NCT01960829

Unknown status

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Conditions: Melanoma; TOR Serine-Threonine Kinases; Neoplasm Metastasis
NCT02145949

Recruiting

Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults

Conditions: Muscle Atrophy; Quality of Life
NCT03616834

Active, not recruiting

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Conditions: Solid Tumors
NCT03306498

Unknown status

Plasma Free Amino Acids in Patients With Hepatic Encephalopathy

Conditions: Hepatic Encephalopathy
NCT00228943

Completed

The Role of Serotonin in Hot Flashes After Breast Cancer

Conditions: Breast Cancer
NCT02987959

Active, not recruiting

Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

Conditions: Soft-tissue Sarcoma
NCT03017768

Completed

The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers

Conditions: Esophageal Sensitivity
NCT02304809

Active, not recruiting

Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations

Conditions: Solid Tumors; Hematologic Cancers; Metastatic Cancers
NCT03690141

Completed

An Open-label Study Examining the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (CRPC)

Conditions: Castrate-resistant Prostate Cancer (CRPC)
NCT04434040

Suspended

Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

Conditions: Breast Cancer; Triple Negative Breast Cancer; Residual Cancer; Circulating Tumor DNA
NCT03328273

Recruiting

A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Conditions: Chronic Lymphocytic Leukemia
NCT03669601

Recruiting

AZD6738 & Gemcitabine as Combination Therapy

Conditions: Cancer
NCT02427893

Withdrawn

Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma

Conditions: Melanoma
NCT03433183

Recruiting

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Conditions: Malignant Peripheral Nerve Sheath Tumors; Neurofibromatosis 1
NCT01149434

Terminated

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

Conditions: Cancer; Neuroendocrine; Ovarian Cancer; Colon Cancer
NCT03143985

Recruiting

Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT02619669

Withdrawn

Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

Conditions: Breast Cancer
NCT03022409

Recruiting

A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).

Conditions: Head and Neck Squamous Cell Carcinoma